These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10398159)
1. Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. Scarpino S; Stoppacciaro A; Pellegrini C; Marzullo A; Zardi L; Tartaglia F; Viale G; Ruco LP J Pathol; 1999 Jun; 188(2):163-7. PubMed ID: 10398159 [TBL] [Abstract][Full Text] [Related]
2. Expression of EDA+ and EDB+ fibronectin splice variants in bone. Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214 [TBL] [Abstract][Full Text] [Related]
3. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667 [TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. Holm R; Nesland JM J Pathol; 1994 Mar; 172(3):267-72. PubMed ID: 8195930 [TBL] [Abstract][Full Text] [Related]
5. Loss of EDB+ fibronectin isoform is associated with differentiation of alveolar epithelial cells in human fetal lung. Arai H; Hirano H; Mushiake S; Nakayama M; Takada G; Sekiguchi K Am J Pathol; 1997 Aug; 151(2):403-12. PubMed ID: 9250153 [TBL] [Abstract][Full Text] [Related]
6. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118 [TBL] [Abstract][Full Text] [Related]
7. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. Gould VE; Martinez-Lacabe V; Virtanen I; Sahlin KM; Schwartz MM Lab Invest; 1992 Jul; 67(1):71-9. PubMed ID: 1378105 [TBL] [Abstract][Full Text] [Related]
8. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast. Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813 [TBL] [Abstract][Full Text] [Related]
10. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing. Kilian O; Dahse R; Alt V; Zardi L; Hentschel J; Schnettler R; Kosmehl H Calcif Tissue Int; 2008 Aug; 83(2):101-11. PubMed ID: 18663401 [TBL] [Abstract][Full Text] [Related]
11. [The relationship between expression of FN in human skin injury and early injury time]. Xue AM; Zhao ZQ; Shen YW Fa Yi Xue Za Zhi; 2003; 19(3):140-2. PubMed ID: 13677314 [TBL] [Abstract][Full Text] [Related]
12. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas. Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronan expression in differentiated thyroid carcinoma. Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369 [TBL] [Abstract][Full Text] [Related]
14. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma. de Souza Meyer EL; Dora JM; Wagner MS; Maia AL Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828 [TBL] [Abstract][Full Text] [Related]
15. Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4. Baelde HJ; Eikmans M; van Vliet AI; Bergijk EC; de Heer E; Bruijn JA J Pathol; 2004 Nov; 204(3):248-57. PubMed ID: 15372454 [TBL] [Abstract][Full Text] [Related]
16. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838 [TBL] [Abstract][Full Text] [Related]
17. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma. Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536 [TBL] [Abstract][Full Text] [Related]
18. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells. Scarpino S; Di Napoli A; Melotti F; Talerico C; Cancrini A; Ruco L J Pathol; 2007 Aug; 212(4):411-9. PubMed ID: 17573672 [TBL] [Abstract][Full Text] [Related]
19. [Molecular cloning of recombinant fibronectin EDA and EDB fusion protein]. Xue AM; Wang H; Ye R Fa Yi Xue Za Zhi; 2002 Aug; 18(3):140-3. PubMed ID: 12608290 [TBL] [Abstract][Full Text] [Related]
20. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]